{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:33:18Z","timestamp":1740166398495,"version":"3.37.3"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01AI153064","T32AI134646","P01AI158571","R01AI146101"],"award-info":[{"award-number":["R01AI153064","T32AI134646","P01AI158571","R01AI146101"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102279","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:27:48Z","timestamp":1721438868000},"page":"102279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The roles of CD4+ T\u00a0cell help, sex, and dose in the induction of protective CD8+ T\u00a0cells against a lethal poxvirus by mRNA-LNP vaccines"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-7237","authenticated-orcid":false,"given":"Samita","family":"Kafle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1969-2911","authenticated-orcid":false,"given":"Brian","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5416-5033","authenticated-orcid":false,"given":"Lingjuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-6242","authenticated-orcid":false,"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-5472","authenticated-orcid":false,"given":"Luis J.","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102279_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2024.102279_bib2","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2024.102279_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102279_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2024.102279_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2024.102279_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14760584.2019.1635463","article-title":"Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)","volume":"18","author":"Thompson","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtn.2024.102279_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111953","article-title":"Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2","volume":"142","author":"Granados-Riveron","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2024.102279_bib12","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102279_bib13","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102279_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102279_bib16","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102279_bib10","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.ymthe.2021.05.011","article-title":"Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T\u00a0cells against a lethal viral infection","volume":"29","author":"Knudson","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102279_bib19","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","article-title":"SARS-CoV-2-specific T\u00a0cells in the changing landscape of the COVID-19 pandemic","volume":"55","author":"Bertoletti","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2024.102279_bib20","article-title":"Count on us: T\u00a0cells in SARS-CoV-2 infection and vaccination","volume":"3","author":"Kedzierska","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1126\/science.add2897","article-title":"T cell immunity to COVID-19 vaccines","volume":"377","author":"Wherry","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102279_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice","volume":"15","author":"Ramos da Silva","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8\u00a0T Cell Response to Respiratory Virus Infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.192.10.1403","article-title":"Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation","volume":"192","author":"Sutton","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib26","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1202143109","article-title":"Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection","volume":"109","author":"Fang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102279_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00566-21","article-title":"Mechanisms of Antiviral Cytotoxic CD4\u00a0T\u00a0Cell Differentiation","volume":"95","author":"Knudson","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102279_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","article-title":"CD4 CTL, a Cytotoxic Subset of CD4(+) T Cells, Their Differentiation and Function","volume":"8","author":"Takeuchi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fimmu.2017.00019","article-title":"Cytotoxic CD4\u00a0T Cells-Friend or Foe during Viral Infection?","volume":"8","author":"Juno","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bj.2019.06.002","article-title":"Regulation of B cell responses by distinct populations of CD4 T\u00a0cells","volume":"42","author":"Aloulou","year":"2019","journal-title":"Biomed. J."},{"key":"10.1016\/j.omtn.2024.102279_bib31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220195","article-title":"B-1 plasma cells require non-cognate CD4 T\u00a0cell help to generate a unique repertoire of natural IgM","volume":"220","author":"Smith","year":"2023","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib32","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1073\/pnas.1808849116","article-title":"CD4(+) T help promotes influenza virus-specific CD8(+) T\u00a0cell memory by limiting metabolic dysfunction","volume":"116","author":"Cullen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102279_bib33","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-019-13438-1","article-title":"CD4(+) T\u00a0cell help creates memory CD8(+) T\u00a0cells with innate and help-independent recall capacities","volume":"10","author":"Ahrends","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102279_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12026-007-0081-4","article-title":"CD8 T\u00a0cell memory development: CD4 T\u00a0cell help is appreciated","volume":"39","author":"Khanolkar","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.omtn.2024.102279_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.coi.2004.03.004","article-title":"Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses","volume":"16","author":"Rocha","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb6852","article-title":"Tissue-resident CD4(+) T helper cells assist the development of protective respiratory B and CD8(+) T\u00a0cell memory responses","volume":"6","author":"Son","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib37","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/eji.201142205","article-title":"From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help","volume":"42","author":"Wiesel","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni1105","article-title":"CD4+ T\u00a0cells are required for the maintenance, not programming, of memory CD8+ T\u00a0cells after acute infection","volume":"5","author":"Sun","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/328077a0","article-title":"Induction of cytotoxic T-cell responses in\u00a0vivo in the absence of CD4 helper cells","volume":"328","author":"Buller","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102279_bib40","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8+ T\u00a0cells are complementary and essential for natural resistance to a highly lethal cytopathic virus","volume":"175","author":"Fang","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib41","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.1200799","article-title":"CD8 T\u00a0cells are essential for recovery from a respiratory vaccinia virus infection","volume":"189","author":"Goulding","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41577-020-0359-5","article-title":"Dissecting antibody-mediated protection against SARS-CoV-2","volume":"20","author":"Zohar","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib43","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102279_bib44","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2015.11.015","article-title":"Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection","volume":"43","author":"Xu","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2024.102279_bib45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.chom.2013.04.015","article-title":"Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection","volume":"13","author":"Rubio","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2024.102279_bib46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0147-9571(96)00013-6","article-title":"Soluble interferon-gamma receptors encoded by poxviruses","volume":"19","author":"Alcami","year":"1996","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102279_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T\u00a0cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib48","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1128\/JVI.02176-14","article-title":"CD4+ T\u00a0cell help is dispensable for protective CD8+ T\u00a0cell memory against mousepox virus following vaccinia virus immunization","volume":"89","author":"Fang","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102279_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01313876","article-title":"Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. V. Genetics of resistance to the Moscow strain","volume":"107","author":"Brownstein","year":"1989","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omtn.2024.102279_bib50","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1128\/jvi.55.3.890-891.1985","article-title":"Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality","volume":"55","author":"Wallace","year":"1985","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102279_bib51","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ymthe.2024.04.019","article-title":"mRNA-LNP vaccine-induced CD8(+) T\u00a0cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies","volume":"32","author":"Montoya","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102279_bib52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102279_bib53","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.154.9.4414","article-title":"Antigen processing in\u00a0vivo and the elicitation of primary CTL responses","volume":"154","author":"Restifo","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib54","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.omtn.2024.102279_bib55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102279_bib56","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/j.celrep.2020.02.111","article-title":"Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity","volume":"30","author":"Ols","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2024.102279_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.612747","article-title":"Optimize Prime\/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game","volume":"12","author":"Palgen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib58","article-title":"Delivery Routes for COVID-19 Vaccines","volume":"9","author":"Park","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2024.102279_bib59","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.vaccine.2005.10.023","article-title":"Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants","volume":"24","author":"Punjabi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2024.102279_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645210","article-title":"Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response","volume":"12","author":"Rosenbaum","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102279_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-18","article-title":"Factors That Influence the Immune Response to Vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtn.2024.102279_bib62","article-title":"Adverse event reports following yellow fever vaccination, 2007-13","volume":"23","author":"Lindsey","year":"2016","journal-title":"J.\u00a0Travel Med."},{"key":"10.1016\/j.omtn.2024.102279_bib63","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2024.102279_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.omtn.2024.102279_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","article-title":"Sex differences in vaccine-induced humoral immunity","volume":"41","author":"Fischinger","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.omtn.2024.102279_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.omtn.2024.102279_bib67","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.vaccine.2017.03.035","article-title":"Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15","volume":"35","author":"Harris","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2024.102279_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-018-0185-z","article-title":"The X chromosome and sex-specific effects in infectious disease susceptibility","volume":"13","author":"Schurz","year":"2019","journal-title":"Hum. Genom."},{"key":"10.1016\/j.omtn.2024.102279_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4049\/immunohorizons.1800066","article-title":"Differential Sensitivity to IL-12 Drives Sex-Specific Differences in the CD8+ T Cell Response to Infection","volume":"3","author":"Yee Mon","year":"2019","journal-title":"Immunohorizons"},{"key":"10.1016\/j.omtn.2024.102279_bib73","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102279_bib70","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","volume":"31","author":"Pine","year":"2023","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T07:35:32Z","timestamp":1726385732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162253124001665"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102279","relation":{},"ISSN":["2162-2531"],"issn-type":[{"type":"print","value":"2162-2531"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The roles of CD4+ T\u00a0cell help, sex, and dose in the induction of protective CD8+ T\u00a0cells against a lethal poxvirus by mRNA-LNP vaccines","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102279"}}